REMEDIES FOR DEPRESSION CONTAINING EP1 ANTAGONIST AS THE ACTIVE INGREDIENT

Details for Australian Patent Application No. 2002238875 (hide)

Owner ONO PHARMACEUTICAL CO., LTD.

Inventors NONAKA, Shigeyuki; MARUYAMA, Takayuki

Pub. Number AU-A-2002238875

PCT Pub. Number WO2002/072145

Priority 2001-73011 14.03.01 JP

Filing date 13 March 2002

Wipo publication date 24 September 2002

International Classifications

A61K 045/00 Medicinal preparations containing active ingredients not provided for in groups

A61K 031/341 - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

A61K 031/426 - 1,3-Thiazoles

A61K 031/4402 - only substituted in position 2, e.g. pheniramine, bisacodyl

A61K 031/4406 - only substituted in position 3, e.g. zimeldine

A61K 031/41 - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 031/427 - not condensed and containing further heterocyclic rings

A61K 031/4439

A61K 031/4245 - Oxadiazoles

C07D 307/64 Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 277/36 Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 213/71 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 403/12 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 417/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

C07D 413/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 405/12 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61P 043/00 Drugs for specific purposes, not provided for in groups

A61P 025/24 Drugs for disorders of the nervous system

Event Publications

20 March 2003 Application Open to Public Inspection

  Published as AU-A-2002238875

12 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002238876-REMEDIES FOR SOLID CANCER CONTAINING HYDROXAMIC ACID DERIVATIVES AS THE ACTIVE INGREDIENT

2002238874-METHOD FOR SELECTING DRUG SENSITIVITY-DETERMINING FACTORS AND METHOD FOR PREDICTING DRUG SENSITIVITY USING THE SELECTED FACTORS